- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 60.81M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $84.28M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $76.36M |
| Short Term Investments | Q1 2025 · Mar 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $34.53M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $52.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $19.41M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $25.69M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $25.86M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $32.81M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $145.6M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $156.94M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $168.03M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $180.32M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 61.19M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $39K |
| Capex | Q1 2025 · Mar 31, 2024 | $688K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.33M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $193.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $200.34M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $11.16M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12.08M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.58M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$12.33M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $26.72M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $8.85M |
| Revenue | Q1 2025 · Mar 31, 2024 | $35.57M |